These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 22227864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
    Akil A, Devlin B, Cost M, Rohan LC.
    Mol Pharm; 2014 May 05; 11(5):1533-41. PubMed ID: 24693866
    [Abstract] [Full Text] [Related]

  • 6. Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery.
    Krogstad EA, Woodrow KA.
    Int J Pharm; 2014 Nov 20; 475(1-2):282-91. PubMed ID: 25169075
    [Abstract] [Full Text] [Related]

  • 7. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ, Hanes J, Shattock R, Cone RA, Friend DR.
    Antiviral Res; 2010 Dec 20; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dead-end complexes contribute to the synergistic inhibition of HIV-1 RT by the combination of rilpivirine, emtricitabine, and tenofovir.
    Kulkarni R, Feng JY, Miller MD, White KL.
    Antiviral Res; 2014 Jan 20; 101():131-5. PubMed ID: 24291780
    [Abstract] [Full Text] [Related]

  • 17. Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.
    Dang NT, Sivakumaran H, Harrich D, Shaw PN, Davis-Poynter N, Coombes AG.
    Eur J Pharm Biopharm; 2014 Oct 20; 88(2):406-14. PubMed ID: 24887313
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.
    Rohan LC, Moncla BJ, Kunjara Na Ayudhya RP, Cost M, Huang Y, Gai F, Billitto N, Lynam JD, Pryke K, Graebing P, Hopkins N, Rooney JF, Friend D, Dezzutti CS.
    PLoS One; 2010 Feb 19; 5(2):e9310. PubMed ID: 20174579
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.